|
US4522803A
(en)
*
|
1983-02-04 |
1985-06-11 |
The Liposome Company, Inc. |
Stable plurilamellar vesicles, their preparation and use
|
|
US4603044A
(en)
|
1983-01-06 |
1986-07-29 |
Technology Unlimited, Inc. |
Hepatocyte Directed Vesicle delivery system
|
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
US4708861A
(en)
|
1984-02-15 |
1987-11-24 |
The Liposome Company, Inc. |
Liposome-gel compositions
|
|
US4863896A
(en)
|
1984-05-03 |
1989-09-05 |
Technology Unlimited, Inc. |
Diabetic control by combined insulin forms
|
|
US5019369A
(en)
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
|
US4946787A
(en)
|
1985-01-07 |
1990-08-07 |
Syntex (U.S.A.) Inc. |
N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US4762915A
(en)
|
1985-01-18 |
1988-08-09 |
Liposome Technology, Inc. |
Protein-liposome conjugates
|
|
US4740375A
(en)
|
1985-02-25 |
1988-04-26 |
Technology Unlimited, Inc. |
Gelcores
|
|
MX9203291A
(es)
|
1985-06-26 |
1992-08-01 |
Liposome Co Inc |
Metodo para acoplamiento de liposomas.
|
|
US5059421A
(en)
|
1985-07-26 |
1991-10-22 |
The Liposome Company, Inc. |
Preparation of targeted liposome systems of a defined size distribution
|
|
GB8522963D0
(en)
|
1985-09-17 |
1985-10-23 |
Biocompatibles Ltd |
Microcapsules
|
|
US5000960A
(en)
|
1987-03-13 |
1991-03-19 |
Micro-Pak, Inc. |
Protein coupling to lipid vesicles
|
|
EP0577146A3
(en)
|
1988-05-16 |
1994-02-02 |
NeXstar Pharmaceuticals, Inc. |
Liposomes coupled to hormones
|
|
DE3919982A1
(de)
|
1989-06-19 |
1990-12-20 |
Liedtke Pharmed Gmbh |
Orale lipidarzneiform
|
|
US5104661A
(en)
|
1989-08-14 |
1992-04-14 |
Technology Unlimited, Inc. |
Reverse loading of liposomes
|
|
JP2599492B2
(ja)
|
1990-08-21 |
1997-04-09 |
第一製薬株式会社 |
リポソーム製剤の製造法
|
|
US5543390A
(en)
|
1990-11-01 |
1996-08-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University |
Covalent microparticle-drug conjugates for biological targeting
|
|
JPH0712424B2
(ja)
*
|
1991-06-21 |
1995-02-15 |
太陽化学株式会社 |
リポソーム
|
|
US5567432A
(en)
|
1991-08-02 |
1996-10-22 |
Lau; John R. |
Masking of liposomes from RES recognition
|
|
US5411730A
(en)
|
1993-07-20 |
1995-05-02 |
Research Corporation Technologies, Inc. |
Magnetic microparticles
|
|
US5514670A
(en)
|
1993-08-13 |
1996-05-07 |
Pharmos Corporation |
Submicron emulsions for delivery of peptides
|
|
US6692766B1
(en)
|
1994-06-15 |
2004-02-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Controlled release oral drug delivery system
|
|
US6027726A
(en)
|
1994-09-30 |
2000-02-22 |
Inex Phamaceuticals Corp. |
Glycosylated protein-liposome conjugates and methods for their preparation
|
|
GB9426484D0
(en)
*
|
1994-12-08 |
1995-03-08 |
Ciba Geigy Ag |
Compositions
|
|
US6004583A
(en)
|
1995-03-22 |
1999-12-21 |
Orex Pharmaceutical Development Corp. |
Protein-containing polymer composition for oral administration
|
|
US5690907A
(en)
|
1995-06-08 |
1997-11-25 |
The Jewish Hospital Of St. Louis |
Avidin-biotin conjugated emulsions as a site specific binding system
|
|
US5968972A
(en)
|
1995-10-26 |
1999-10-19 |
Baker Norton Pharmaceuticals, Inc. |
Method for increasing the oral bioactivity of pharmaceutical agents
|
|
EP0904100B1
(en)
|
1996-02-09 |
2006-07-26 |
Pi-Wan Cheng |
Cationic lipid and receptor ligand-facilitated delivery of biologically active molecules
|
|
US6207185B1
(en)
|
1996-03-22 |
2001-03-27 |
Bio-Sphere Technology |
Method for inducing a systemic immune response to an HIV antigen
|
|
US6565889B2
(en)
|
1996-12-02 |
2003-05-20 |
The Regents Of The University Of California |
Bilayer structure which encapsulates multiple containment units and uses thereof
|
|
US5795895A
(en)
|
1997-06-13 |
1998-08-18 |
Anchors; J. Michael |
Combination anorexiant drug therapy for obesity using phentermine and an SSRI drug
|
|
EP1005327A1
(en)
|
1997-07-02 |
2000-06-07 |
Sdg, Inc. |
Targeted liposomal constructs for diagnostic and therapeutic uses
|
|
AU9221698A
(en)
|
1997-09-04 |
1999-03-22 |
Biozone Laboratories, Inc. |
Oral liposomal delivery system
|
|
JPH11116478A
(ja)
|
1997-10-08 |
1999-04-27 |
Taisho Pharmaceut Co Ltd |
肥満防止剤
|
|
AU2669599A
(en)
|
1998-02-12 |
1999-08-30 |
Regents Of The University Of California, The |
Compositions for receptor/liposome mediated transfection and methods of using same
|
|
AU3999699A
(en)
|
1998-05-19 |
1999-12-06 |
Sdg, Inc. |
Targeted liposomal drug delivery system
|
|
US7169410B1
(en)
|
1998-05-19 |
2007-01-30 |
Sdg, Inc. |
Targeted liposomal drug delivery system
|
|
US7871641B2
(en)
|
1998-05-19 |
2011-01-18 |
Sdg, Inc. |
Hepatocyte-targeting vehicle for delivery of glargine insulin to a mammal
|
|
WO1999065467A1
(en)
|
1998-06-16 |
1999-12-23 |
See Jackie R |
Method for introducing a chemical agent into the systemic circulation
|
|
WO2000024377A1
(en)
*
|
1998-10-23 |
2000-05-04 |
Idea Innovative Dermale Applikationen Gmbh |
Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates
|
|
AU1921900A
(en)
|
1998-12-01 |
2000-06-19 |
Sdg, Inc. |
A polysome
|
|
US6365156B1
(en)
|
1999-04-16 |
2002-04-02 |
Osel, Inc. |
Method for improving the half-life of soluble viral-specific ligands on mucosal membranes
|
|
EP1563832A1
(en)
|
1999-04-23 |
2005-08-17 |
Mitsubishi Chemical Corporation |
Liposome comprising a compound containing 2 polyalkylene glycol groups
|
|
CN1221283C
(zh)
|
1999-05-19 |
2005-10-05 |
沈阳药科大学 |
口服胰岛素微粒剂及其制备方法
|
|
US7098032B2
(en)
|
2001-01-02 |
2006-08-29 |
Mirus Bio Corporation |
Compositions and methods for drug delivery using pH sensitive molecules
|
|
US6458382B1
(en)
|
1999-11-12 |
2002-10-01 |
Mirus Corporation |
Nucleic acid transfer complexes
|
|
US6761901B1
(en)
|
2000-05-02 |
2004-07-13 |
Enzrel Inc. |
Liposome drug delivery
|
|
US20030133972A1
(en)
|
2000-10-11 |
2003-07-17 |
Targesome, Inc. |
Targeted multivalent macromolecules
|
|
AU2002232394A1
(en)
|
2000-10-27 |
2002-05-27 |
Wayne State University |
Inhibition of alpha-2 hs glycoprotein (ahsg/fetuin) in obesity and insulin control of glucose homeostasis
|
|
WO2002056831A2
(en)
|
2000-12-27 |
2002-07-25 |
Dana-Farber Cancer Institute, Inc. |
Immunogenic proteoliposomes, and uses thereof
|
|
US20030068361A1
(en)
|
2001-10-09 |
2003-04-10 |
Rimona Margalit |
Liposome-encapsulated insulin formulations
|
|
WO2004046685A2
(en)
|
2002-07-15 |
2004-06-03 |
Technical Instrument San Francisco |
Quality control of assays
|
|
US7678386B2
(en)
|
2002-07-15 |
2010-03-16 |
Board Of Regents The University Of Texas |
Liposomes coated with selected antibodies that bind to aminophospholipids
|
|
AU2003304211A1
(en)
|
2002-10-30 |
2005-01-04 |
The Regents Of The University Of California |
Direct micro-patterning of lipid bilayers using uv light and selected uses thereof
|
|
US20050026826A1
(en)
|
2003-01-17 |
2005-02-03 |
Margarethe Hoenig |
Feline proinsulin, insulin and constituent peptides
|
|
US9872890B2
(en)
|
2003-03-19 |
2018-01-23 |
Paul C. Davidson |
Determining insulin dosing schedules and carbohydrate-to-insulin ratios in diabetic patients
|
|
WO2004097372A2
(en)
|
2003-04-28 |
2004-11-11 |
The Regents Of The University Of California |
Element-coded affinity tags
|
|
CN103585136A
(zh)
|
2003-05-20 |
2014-02-19 |
约翰霍普金斯大学 |
用于治疗肿瘤的邻苯二酚丁烷的释放的方法和组合物
|
|
WO2005029078A1
(en)
|
2003-09-17 |
2005-03-31 |
Guava Technologies, Inc. |
Compositions and methods for analysis of target analytes
|
|
JP2007511616A
(ja)
|
2003-11-19 |
2007-05-10 |
バーンズ−ジューイッシュ ホスピタル |
増強された薬物送達
|
|
US20050202075A1
(en)
|
2004-03-12 |
2005-09-15 |
Pardridge William M. |
Delivery of genes encoding short hairpin RNA using receptor-specific nanocontainers
|
|
US7511016B2
(en)
|
2004-07-07 |
2009-03-31 |
Mosamedix B.V. |
Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof
|
|
WO2006127361A2
(en)
|
2005-05-23 |
2006-11-30 |
Sdg, Inc. |
Lipid construct for delivery of insulin to a mammal
|
|
US20110135725A1
(en)
|
2005-05-23 |
2011-06-09 |
Sdg, Inc. |
Lipid Construct for Delivery of Insulin to a Mammal
|
|
CN101237854B
(zh)
*
|
2005-05-23 |
2013-03-27 |
Sdg公司 |
将胰岛素输送到哺乳动物的脂构建体
|
|
US20070218117A1
(en)
*
|
2006-03-20 |
2007-09-20 |
Sdg, Inc. |
Supra molecular construct for delivery of interferon to a mammal
|
|
US20080207490A1
(en)
|
2005-07-07 |
2008-08-28 |
Postech Foundation |
Glucose Uptake Modulator and Method for Treating Diabetes or Diabetic Complications
|
|
CN1895224A
(zh)
|
2006-06-26 |
2007-01-17 |
裴泽军 |
多烯磷脂酰胆碱脂质体制剂及其制备方法
|
|
US9814672B2
(en)
|
2007-03-09 |
2017-11-14 |
Susan T. Laing |
Echogenic vehicle for clinical delivery of plasminogen activator and other fibrin-binding therapeutics to thrombi
|
|
US8846053B2
(en)
*
|
2008-09-26 |
2014-09-30 |
Sdg, Inc. |
Orally bioavailable lipid-based constructs
|
|
US20100080773A1
(en)
|
2008-09-26 |
2010-04-01 |
Sdg, Inc. |
Orally Bioavailable Lipid-Based Constructs
|
|
US9145453B2
(en)
|
2007-09-28 |
2015-09-29 |
Sdg, Inc. |
Orally bioavailable lipid-based constructs
|
|
US8962015B2
(en)
*
|
2007-09-28 |
2015-02-24 |
Sdg, Inc. |
Orally bioavailable lipid-based constructs
|
|
US20120128767A1
(en)
*
|
2008-05-01 |
2012-05-24 |
Lee William W |
Therapeutic calcium phosphate particles and methods of making and using same
|
|
WO2010080976A1
(en)
|
2009-01-09 |
2010-07-15 |
Sdg, Inc. (An Ohio Corporation) |
Insulin therapies for the treatment of diabetes, diabetes related ailments, and/or diseases or conditions other than diabetes or diabetes related ailments
|
|
GB2477545B
(en)
*
|
2010-02-05 |
2011-12-21 |
Special Products Ltd |
A liquid morphine composition for buccal administration
|
|
ES2384060B1
(es)
*
|
2010-03-24 |
2013-09-23 |
Lipotec S.A. |
Cápsulas de nanopartículas lipídicas.
|
|
GB201215289D0
(en)
*
|
2012-08-28 |
2012-10-10 |
Medical Res Council |
Nanoparticle formulation
|
|
KR101951933B1
(ko)
|
2013-03-12 |
2019-02-25 |
주식회사 아리바이오 |
라이소포스파티딜콜린 또는 이의 유도체를 포함하는 지질나노물질 및 이의 제조방법
|
|
US20180000953A1
(en)
*
|
2015-01-21 |
2018-01-04 |
Moderna Therapeutics, Inc. |
Lipid nanoparticle compositions
|
|
US20180110771A1
(en)
|
2016-10-21 |
2018-04-26 |
Ipsen Biopharm Ltd. |
Liposomal Irinotecan Preparations
|
|
US20170319573A1
(en)
*
|
2015-10-16 |
2017-11-09 |
Ipsen Biopharm Ltd. |
Stabilizing Camptothecin Pharmaceutical Compositions
|
|
WO2018169954A1
(en)
|
2017-03-13 |
2018-09-20 |
Sdg, Inc. |
Lipid-based nanoparticles with enhanced stability
|
|
US11077173B2
(en)
*
|
2017-03-13 |
2021-08-03 |
Sdg, Inc. |
Lipid-based nanoparticles and methods using same
|
|
KR20200106912A
(ko)
|
2018-01-05 |
2020-09-15 |
에스디지,인코포레이티드 |
당뇨병을 치료하기 위한 지질 기반 나노입자를 포함하는 조성물
|
|
WO2020210697A1
(en)
*
|
2019-04-12 |
2020-10-15 |
Sdg, Inc. |
Lipid-based nanoparticles and use of same in optimized insulin dosing regimens
|